Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xiaofeng Zhou
Observed name:
X Y Zhou
Institutions:
Second Affiliated Hospital of Zhejiang University,
Zhejiang University
Observed institutions:
Nanjing University of Chinese Medicine,
China-Japan Friendship Hospital,
Nanjing Drum Tower Hospital,
Second Affiliated Hospital of Zhejiang University,
Zhejiang University
ORCID:
0000-0001-5088-9985
Observed ORCID:
0000-0001-5088-9985
OpenAlex ID:
A5114593951
Recurrence patterns in patients with high-grade glioma following temozolomide-based chemoradiotherapy
2016
·
Xiaofeng Zhou
, Xiaofang Liao
, et al.
·
Molecular and Clinical Oncology
·
38
PDF
lncRNA-UCA1 in the diagnosis of bladder cancer: A meta-analysis
2021
·
Zhenshan Ding
, Wenwei Ying
, et al.
·
Medicine
·
24
HER2 expression in primary gastric cancers and paired synchronous lymph node and liver metastases. A possible road to target HER2 with radionuclides
2014
·
Qichun Wei
, Jing Xu
, et al.
·
Tumor Biology
·
7
Nomograms for predicting progression-free survival and overall survival after surgery and concurrent chemoradiotherapy for glioblastoma: a retrospective cohort study
2021
·
Lin Zheng
, Zhi-Rui Zhou
, et al.
·
Annals of Translational Medicine
·
5
PDF
[Progress in evaluating the risk of lymph node metastasis in early colorectal cancer].
2023
·
X Y Zhou
, K F Ding
, et al.
·
PubMed
·
3
[Exploration of biomarkers for the efficacy of anti-PD-1 immunotherapy in patients with gastric cancer peritoneal metastasis].
2025
·
Y T Wei
, Y Wang
, et al.
·
PubMed
·
1
Osteomalacia Caused by a Phosphaturic Mesenchymal Tumor Detected by 18F-AlF-NOTA-octreotide PET/CT
2026
·
Haifeng Hou
, Shouhong Zhang
, et al.
·
Nuclear Medicine and Molecular Imaging
18F-FDG PET/CT Reveals Heterogeneous Treatment Response with Isolated CNS Progression in Myeloid Sarcoma
2026
·
Haifeng Hou
, Shouhong Zhang
, et al.
·
Nuclear Medicine and Molecular Imaging
Show more works
View as search
Works count:
8
Citation count:
78
H-index:
4
I10-index:
2
Year
Topic
Type